Literature DB >> 30716416

Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT2A receptor activation.

Sean C Godar1, Laura J Mosher2, Simona Scheggi3, Paola Devoto4, Kelly M Moench5, Hunter J Strathman2, Cori M Jones6, Roberto Frau4, Miriam Melis4, Carla Gambarana7, Brent Wilkinson8, M Graziella DeMontis7, Stephen C Fowler6, Marcelo P Coba8, Cara L Wellman5, Jean C Shih9, Marco Bortolato10.   

Abstract

The ontogeny of antisocial behavior (ASB) is rooted in complex gene-environment (G×E) interactions. The best-characterized of these interplays occurs between: a) low-activity alleles of the gene encoding monoamine oxidase A (MAOA), the main serotonin-degrading enzyme; and b) child maltreatment. The purpose of this study was to develop the first animal model of this G×E interaction, to help understand the neurobiological mechanisms of ASB and identify novel targets for its therapy. Maoa hypomorphic transgenic mice were exposed to an early-life stress regimen consisting of maternal separation and daily intraperitoneal saline injections and were then compared with their wild-type and non-stressed controls for ASB-related neurobehavioral phenotypes. Maoa hypomorphic mice subjected to stress from postnatal day (PND) 1 through 7 - but not during the second postnatal week - developed overt aggression, social deficits and abnormal stress responses from the fourth week onwards. On PND 8, these mice exhibited low resting heart rate - a well-established premorbid sign of ASB - and a significant and selective up-regulation of serotonin 5-HT2A receptors in the prefrontal cortex. Notably, both aggression and neonatal bradycardia were rescued by the 5-HT2 receptor antagonist ketanserin (1-3 mg kg-1, IP), as well as the selective 5-HT2A receptor blocker MDL-100,907 (volinanserin, 0.1-0.3 mg kg-1, IP) throughout the first postnatal week. These findings provide the first evidence of a molecular basis of G×E interactions in ASB and point to early-life 5-HT2A receptor activation as a key mechanism for the ontogeny of this condition. This article is part of the Special Issue entitled 'The neuropharmacology of social behavior: from bench to bedside'.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Aggression; Animal models; Antisocial behavior; Gene-environment interactions; Serotonin

Mesh:

Substances:

Year:  2019        PMID: 30716416      PMCID: PMC7578912          DOI: 10.1016/j.neuropharm.2019.01.028

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  64 in total

Review 1.  Early-life handling stimulation and environmental enrichment: are some of their effects mediated by similar neural mechanisms?

Authors:  Alberto Fernández-Teruel; Lydia Giménez-Llort; Rosa M Escorihuela; Luis Gil; Raúl Aguilar; Thierry Steimer; Adolf Tobeña
Journal:  Pharmacol Biochem Behav       Date:  2002-08       Impact factor: 3.533

2.  Developmental regulation of 5-HT2 and 5-HT1c mRNA and receptor levels.

Authors:  B L Roth; M W Hamblin; R D Ciaranello
Journal:  Brain Res Dev Brain Res       Date:  1991-01-15

3.  Psychopaths lack the automatic avoidance of social threat: relation to instrumental aggression.

Authors:  Anna Katinka Louise von Borries; Inge Volman; Ellen Rosalia Aloïs de Bruijn; Berend Hendrik Bulten; Robbert Jan Verkes; Karin Roelofs
Journal:  Psychiatry Res       Date:  2012-07-20       Impact factor: 3.222

4.  Emotional Desensitization to Violence Contributes to Adolescents' Violent Behavior.

Authors:  Sylvie Mrug; Anjana Madan; Michael Windle
Journal:  J Abnorm Child Psychol       Date:  2016-01

5.  A Longitudinal Study of Resting Heart Rate and Violent Criminality in More Than 700 000 Men.

Authors:  Antti Latvala; Ralf Kuja-Halkola; Catarina Almqvist; Henrik Larsson; Paul Lichtenstein
Journal:  JAMA Psychiatry       Date:  2015-10       Impact factor: 21.596

6.  Differential susceptibility to the environment: an evolutionary--neurodevelopmental theory.

Authors:  Bruce J Ellis; W Thomas Boyce; Jay Belsky; Marian J Bakermans-Kranenburg; Marinus H van Ijzendoorn
Journal:  Dev Psychopathol       Date:  2011-02

7.  Serotonergic regulation of membrane potential in developing rat prefrontal cortex: coordinated expression of 5-hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 receptors.

Authors:  Jean-Claude Béïque; Brian Campbell; Paul Perring; Mark W Hamblin; Paul Walker; Ljiljana Mladenovic; Rodrigo Andrade
Journal:  J Neurosci       Date:  2004-05-19       Impact factor: 6.167

8.  Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA.

Authors:  O Cases; I Seif; J Grimsby; P Gaspar; K Chen; S Pournin; U Müller; M Aguet; C Babinet; J C Shih
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

9.  Anxiety and fear behaviors in adult male and female C57BL/6 mice are modulated by maternal separation.

Authors:  Russell D Romeo; Astrid Mueller; Helene M Sisti; Sonoko Ogawa; Bruce S McEwen; Wayne G Brake
Journal:  Horm Behav       Date:  2003-05       Impact factor: 3.587

10.  Dopamine D1 receptor-dependent modifications in the dopamine and cAMP-regulated phosphoprotein of Mr 32 kDa phosphorylation pattern in striatal areas of morphine-sensitized rats.

Authors:  S Scheggi; A Crociani; M G De Montis; A Tagliamonte; C Gambarana
Journal:  Neuroscience       Date:  2009-06-25       Impact factor: 3.590

View more
  10 in total

Review 1.  Neuroscience and actometry: An example of the benefits of the precise measurement of behavior.

Authors:  Troy J Zarcone
Journal:  Brain Res Bull       Date:  2022-04-25       Impact factor: 3.715

2.  Elevated levels of serotonin 5-HT2A receptors in the orbitofrontal cortex of antisocial individuals.

Authors:  Giulia Braccagni; Simona Scheggi; Marco Bortolato
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-09-12       Impact factor: 5.760

Review 3.  Defining Transformative Experiences: A Conceptual Analysis.

Authors:  Alice Chirico; Marta Pizzolante; Alexandra Kitson; Elena Gianotti; Bernhard E Riecke; Andrea Gaggioli
Journal:  Front Psychol       Date:  2022-06-24

4.  The steroidogenic inhibitor finasteride reverses pramipexole-induced alterations in probability discounting.

Authors:  Gabriele Floris; Simona Scheggi; Romina Pes; Marco Bortolato
Journal:  Brain Res Bull       Date:  2022-02-03       Impact factor: 3.715

5.  Epigenomics and gene regulation in mammalian social systems.

Authors:  Tania P Guerrero; Jörns Fickel; Sarah Benhaiem; Alexandra Weyrich
Journal:  Curr Zool       Date:  2020-02-25       Impact factor: 2.624

6.  Sex-Dimorphic Interactions of MAOA Genotype and Child Maltreatment Predispose College Students to Polysubstance Use.

Authors:  Paula J Fite; Shaquanna Brown; Waheeda A Hossain; Ann Manzardo; Merlin G Butler; Marco Bortolato
Journal:  Front Genet       Date:  2020-01-17       Impact factor: 4.599

7.  Combined Antagonism of 5-HT2 and NMDA Receptors Reduces the Aggression of Monoamine Oxidase a Knockout Mice.

Authors:  Roberto Frau; Alessandra Pardu; Sean Godar; Valentina Bini; Marco Bortolato
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-10

Review 8.  The Implication of 5-HT Receptor Family Members in Aggression, Depression and Suicide: Similarity and Difference.

Authors:  Nina K Popova; Anton S Tsybko; Vladimir S Naumenko
Journal:  Int J Mol Sci       Date:  2022-08-08       Impact factor: 6.208

9.  Predation Stress Causes Excessive Aggression in Female Mice with Partial Genetic Inactivation of Tryptophan Hydroxylase-2: Evidence for Altered Myelination-Related Processes.

Authors:  Evgeniy Svirin; Ekaterina Veniaminova; João Pedro Costa-Nunes; Anna Gorlova; Aleksei Umriukhin; Allan V Kalueff; Andrey Proshin; Daniel C Anthony; Andrey Nedorubov; Anna Chung Kwan Tse; Susanne Walitza; Lee Wei Lim; Klaus-Peter Lesch; Tatyana Strekalova
Journal:  Cells       Date:  2022-03-18       Impact factor: 6.600

Review 10.  Pivotal mental states.

Authors:  Ari Brouwer; Robin Lester Carhart-Harris
Journal:  J Psychopharmacol       Date:  2020-11-11       Impact factor: 4.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.